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The hydrostatic hyperbaric chamber (HHC) represents the merger of several 
technologies in development for NASA aerospace applications, harnessed to directly benefit 
global health.  NASA has significant experience developing composite hyperbaric chambers 
for a variety of applications.  NASA also has researched the application of water-filled 
vessels to increase tolerance of acceleration forces.  The combination of these two 
applications has resulted in the hydrostatic chamber, which has been conceived as a safe, 
affordable means of making hyperbaric oxygen therapy (HBOT) available in the developing 
world for the treatment of a variety of medical conditions.  Specifically, HBOT is highly-
desired as a possibly curative treatment for Buruli Ulcer, an infectious condition that afflicts 
children in sub-Saharan Africa.  HBOT is simply too expensive and too dangerous to 
implement in the developing world using standard equipment.  The HHC technology 
changes the paradigm.  The HHC differs from standard hyperbaric chambers in that the 
majority of its volume is filled with water which is pressurized by oxygen being supplied in 
the portion of the chamber containing the patient’s head. This greatly reduces the amount of 
oxygen required to sustain a hyperbaric atmosphere, thereby making the system more safe 
and economical to operate.  An effort was taken to develop an HHC system to apply HBOT 
to children that is simple and robust enough to support transport, assembly, maintenance 
and operation in developing countries.  This paper details the concept for an HHC 
ventilation and pressurization system to provide controlled pressurization and adequate 
washout of carbon dioxide while the subject is enclosed in the confined space during the 
administration of the medical treatment.  The concept took into consideration operational 
complexity, safety to the patient and operating personnel, and physiological considerations.  
The simple schematic, comprised of easily acquired commercial hardware, supports 
sustainability. 
Nomenclature 
atm = atmosphere, standard 
CO2
HBOT = hyperbaric oxygen therapy 
 = carbon dioxide 
HHC = hydrostatic hyperbaric chamber 
mm Hg = millimeters of mercury 
O2
I. Introduction 
 = oxygen 
he hydrostatic hyperbaric chamber (HHC) represents the merger of several technologies in development for 
NASA aerospace applications, harnessed to directly benefit global health.  NASA has significant experience 
developing composite hyperbaric chambers for a variety of applications, including the treatment of medical 
conditions.  NASA also has researched the application of water-filled vessels to increase tolerance of acceleration 
forces.  The combination of these two applications has resulted in the hydrostatic chamber, which has been 
conceived as a safe, affordable means of making HBOT available in the developing world for the treatment of a 
variety of medical conditions.  Specifically, HBOT is highly-desired as a possibly curative treatment for Buruli 
Ulcer, an infectious condition that afflicts children in sub-Saharan Africa.  HBOT is simply too expensive and too 
dangerous to implement in the Developing World using standard equipment.  The HHC technology changes the 
paradigm.  
                                                          








The HHC differs from standard hyperbaric chambers in that the majority of its volume is filled with water.  
Since water is essentially incompressible, filling the chamber greatly limits the internal volume of compressed gas.  
This decreases the potential energy contained within the chamber, and decreases the overall energy expenditure 
needed to operate the chamber.  The energy requirements for operating a traditional medical hyperbaric chamber 
make it too expensive (and too unsafe) to implement in undeveloped locations.  In contrast, a hydrostatic hyperbaric 
chamber could make HBOT a financially viable treatment option for medical conditions in the developing world.   
Developing a simple hydrostatic hyperbaric system could therefore utilized for compassionate medical care in the 
Developing World with good effect. 
Since the human body is predominantly water, the occupant of a hydrostatic hyperbaric chamber can be made 
neutrally buoyant.  NASA studies have shown that, when subjected to a hyperbaric, hydrostatic pressure, humans 
are capable of withstanding higher g-loads and vibrations. A personal HHC, or launch pod, would be beneficial in 
mitigating the injury to crew during launch.  With respect to commercial applicability, a lighter and less expensive 
HHC’s could be used to make DCS treatment available on more dive boats.  Likewise, a lightweight, low energy 
system could be applied to mitigate the effects of altitude sickness and provide decompression sickness (DCS) 
treatment.  
The objective of this project is to develop and manufacture a portable single-person hydrostatic hyperbaric 
chamber (HHC) that can be used to administer HBOT in developing countries. 
II. Design Considerations 
A. Concept of Operations 
A concept of operations (ConOps) was discussed by the design team in order to draw out the design functions, 
constraints and requirements.   
The HHC components will be manufactured/procured in the locality of treatment administration.  The HHC will 
be transported to the medical facility via a readily available form of transportation, for example a pick-up truck.  No 
special equipment will be required and the environment will not be controlled.  It is assumed that the form of 
transportation is not highly reliable, therefore breakdowns may occur in transit causing significant delays.  At the 
medical facility, “normal” medical equipment such as human grade oxygen, breathing masks and plastic oxygen 
grade tubing will be available.  Local technicians will off-load the HHC from the truck to the administration site and 
assemble the unit.  The seat will be adjusted in accordance with the patient’s size.  The patient will be seated in the 
HHC and the restraints adjusted and secured.  The chamber will be filled with local water to the patient’s collar 
bone.  The chamber is closed.  The chamber is pressurized with breathing gas to the desired pressure.     
The hydrostatic hyperbaric chamber will require a subject to be enclosed in a confined space for about an hour 
during the administration of the medical treatment.  A doctor and support person (e.g. parent) maintains visual 
contact with the patient.  It is expected that the patient may experience convulsions during the treatment and must, 
therefore, be secured so as not to fall under the water level.  The HHC will incorporate a harness to keep the subject 
from submerging into the water portion of the chamber.  If the doctor perceives significant danger to the patient, the 
treatment is stopped.  In an emergency, the chamber is returned to ambient pressure and the water is dumped. The 
chamber is opened and the patient is removed.   
B. Derived requirements 
Based on the ConOps, the key design considerations for the HHC were as follows: 
• Safety: It is NASA policy to protect the public, NASA workforce, high-value equipment and property, and 
the environment from potential harm as a result of NASA activities and operations by factoring safety as an 
integral feature of programs, projects, technologies, operations, and facilities. [NPD 8700.1E] 
• Cost: The upfront cost of the design and manufacture of this system must fall within the project budget 
– Application of this technology to benefit Developing World medical care is contingent on the 
ability to fund the acquisition and sustaining operation of this system 
– Specialized equipment or personnel must not be required to operate or maintain this system 
• Portability: This system must be light enough to be assembled manually and small enough to fit in 
standard modes of transportation available in Developing counties; e.g. a pick-up truck flat bed 
• Reproducibility: It is a goal to have this technology manufactured directly in third world countries 
 
The following are the key driving requirements were derived for the HHC ventilation system:  
• The ventilation system must provide controlled pressurization of the HHC at start up 
 




• The ventilation system must maintain the system at the nominal operating pressure throughout the duration 
of the procedure 
• The ventilation system must mitigate the toxic buildup of CO2
• The ventilation system must accommodate movement of the patient (e.g. convulsions) 
.   
• The ventilation system must allow for visual monitoring of the patient 
• The design must accomodate 5th percentile 5-yr old child through 95th percentile male.  The following 
parameters were taken into consideration when designing the ventilation system: 
o Neutral placement of oral/nasal 
region  
o Head range of motion 
o Breath capacity 
o Inspiration Rate  
o Tidal Volume 
• The design must provide for controlled depressurization at termination of treatment  
• The design must accommodate an emergency termination. 
III. Design Concept 
This ventilation system schematic was intended to be as simple as possible to support operability and 
maintainability.  Figure 1 provides a notional schematic. 
 
Figure 1. Notional Schematic for an HHC Ventilation System 
A. Pressurization System 
The general architecture chosen for the ventilation system is one where oxygen is transmitted to the breathing 
apparatus.  This ventilation flow is used to gradually pressurize the system.  A back pressure regulator at the outlet 
maintains the pressure in the chamber throughout the procedure.  A manual valve is included at the outlet to 
depressurize the chamber at the end of the procedure. 
It is expected that high pressure oxygen will be available locally.  A standard bottle at up to 1000 psi is plumbed 
to a standard fitting on the HHC.  A dual-stage regulator steps the oxygen pressure into the HHC down to an 
acceptable operating pressure (about 2 atm). An inline flow meter is used to control the flow to the breathing 
apparatus.  A checkvalve prevents back flow of expired air into the oxygen supply line.   
A reverse flow regulator is included to support the emergency termination event.  In this scenario, a manual 
valve opens the HHC drain to dump the water from chamber.  Without a way for pressure to equalize with the 
ambient environment, a sub-ambient pressure could be achieved in the chamber posing a risk of decompression 
sickness to the patient.  With certain oxygen delivery methods, there is a risk of incurring a hypoxic environment 
 




until the chamber can be opened.  The reverse flow regulator allows ambient air to enter the chamber thereby 
preventing sub-ambient conditions to occur.   
All of the components in the pressurization subsystem are commercially available.  A sample parts list is 
included in Appendix A. 
B. Oxygen Delivery Subsystem 
The breathing apparatus, or means by which air is delivered to the patient, drives the design of the whole 
ventilation system.  Three ventilation options were evaluated: demand breathing, free volume ventilation (FVV), and 
directed constant flow (DCF).   
Demand breathing systems are used by miners, firefighters and divers (among others).  This option provides 
breathing to the subject via a demand regulator.  A suction force created by the lungs during the inhalation motion 
triggers oxygen flow to the subject.  The air is then exhaled to the chamber.  A relief valve is used to keep the 
chamber from over-pressurizing.  Since air must be delivered to the patients a varying pressures from 1 to 2 atm, a 
self-contained underwater breathing apparatus (SCUBA) system is the most relevant commercially available 
demand breather for the HHC. 
In the FVV concept, pure oxygen is directed into the hyperbaric chamber to pressurize the volume. Inlet and 
outlet flows are then maintained in order to establish a ventilation path in the chamber to mitigate toxic buildup of 
carbon dioxide.  In this scenario, flow must be sufficient to ensure that there is no build-up of CO2
DCF delivers a constant flow of oxygen directly to the subject’s nose and mouth.  Excess oxygen and expired air 
flows to the chamber dome and out through a back-pressure regulator that maintains a constant pressure within the 
chamber.  This option passively ventilates to the chamber dome.    One option (DCF1) is to administer oxygen via a 
pediatric nebulizer mask or standard oxygen mask.  An alternate solution is a face directed spray bar.  This would 
maintain a constant flow of air over the patients face.   
 greater than 
5mmHg anywhere in the gas chamber.  Significantly more oxygen would be required than with a oral-nasal directed 
flow.   
 
Figure 2. Free Volume Ventilation (FVV). 
 
Figure 3. Directed Constant Flow with Oral-Nasal 
Mask (DCF1). 
 
Figure 4. Directed Constant Flow with Overhead 
Spray Bar (DCF2). 
 
A multiobjective analysis (reference Kirkwood) was performed using the key design considerations and 
requirements to establish the evaluation measures.  All options meet basic functionality, therefore the functional 
requirements were not included as evaluation measures.  Additionally, none of the four options challenge portability.  












Figure 5. Preliminary Value Hierarchy for Ventilation System Trade Study. 
 
After preliminary analyses of each evaluation measure, it was determined that the options do not provide a 
significant distinction with respect to CO2
 
 washout or movement accommodation.  No additionally consumables 
were identified for each of the options to affect recurring costs.  Finally, the commercially available equipment was 
identified to support all options such that no specialty parts would be needed for any option.  Four evaluation criteria 
were then used to score the options.  The weights were adjusted to maintain the same relative weights prior to the 
simplification.  The final value hierarchy is shown in Figure 6.   
 
Figure 6. Final HHC Ventilation System Trade Study Value Hierarchy 
 
 
1. Patient Monitoring 
This objective measures the impact to visual monitoring of the patient.  Each option was evaluated – one point 
was given for each visual impediment identified. 
 




The demand breather option requires a full face mask with an attached demand regulator.  The oral nasal region 
of the patient would be completely covered, though clear view of the patients eyes is achieved.  Since there is no 
active ventilation to the chamber, the dome is likely to fog over reducing the care providers ability to visually 
monitor the patient.  There is very little risk that the mask would be displaced during the procedure.  This is also low 
risk of blocking the flow path with spit or vomit. (get a better reference than about.com) 
FVV allows for optimal monitoring of the patient since there is no hardware impeding the view of the patient.  
Additionally, the option allows for flow to be directed to the dome to keep down fogging during the procedure.  The 
flow could be configured to achieve acceptable washout of CO2 (see the figure); some risk of CO2 pockets forming 
remains (reference Augustine’s CO2 washout paper).   
Both DCF options require something to be worn by the patient that channels oxygen directly to the nose and 
mouth region.  The DCF1 mask has some impact on the ability to visually monitor the patient as it will cover the 
oral nasal region of the patient with a translucent plastic. The DCF2 head-mounted spray bay could have a larger 
impact on patient monitoring.  Both options would require some oxygen to be channeled toward the dome to 
mitigate fogging.  Both options will achieve adequate CO2 washout.   
 
2. System Cost  
Only the device that delivers the oxygen to the patient was reviewed for this parameter; the infrastructure to 
provide oxygen to this device is similar for all options.  DBA is the most expensive option, followed by DCF2.  The 
FVV option requires nothing more than the basic pressurization infrastructure and therefore is considered to carry no 
cost. DCF1 requires a very inexpensive oxygen mask.  
 
3. Sizing 
Another aspect to cost involves sizing.  The options that interface with the patient may need various sizes to 
accommodate the patient pool.  Several units would have to be purchased, increasing the system cost.  The FVV 
option does not interface with the patient and, therefore has no additional cost incurred.  The remaining options 
would require at least 2 sizes to accommodate both child and adult physiology.   
 
4. Oxygen Use 
A major aspect of the system’s recurring cost is the oxygen usage.  The DCF options will require about (need to 
recalculate) oxygen per hour of treatment to support a small child to average adult, respectively.    
 
<insert oxygen usage calculations> 
 
The DBA will require less than half the gas as the DCF options since oxygen will only be consumed during 
inhalation.  The FVV option will require significantly more oxygen to ensure adequate CO2 washout.  
A quick test was performed to demonstrate a small volume hatch concept; inspired CO2 was measured given up 
up to 10 lpm oxygen at ambient pressure.  Adequate CO2 washout could not be achieved in the FVV configuration; 
directed flow to the oral-nasal region was required.  This was was very low fidelity test that should be repeated to 
validate flow requirements; but the observations correlated to the trend predicted by the analysis. 
 
5. Trade Study Results 
The following table shows the scores given for each parameter.  FVV is rated to be the best option followed 
closely by the DCF1 option.   
 
Table 1. Oxygen Supply Trade Scores. 
Parameter \ Option DBA FVV DCF1 DCF2 
Fogging 1 0 0.5 0.5 
Blocked view of nose/mouth 1 0 0.5 0 
Blocked view of eyes 0 0 0 1 
Raw Score 2 0 1 1.5 
Value 0.5 1 0.75 0.625 
Weighted Safety (.625) 0.165 0.330 0.248 0.206 
Cost 600(1) 0 2.52(2) 300(3) 
Value 0 1 0.9958 0.5 
 




Weighted Cost (.131) 0.000 0.310 0.309 0.155 
Sizing 1 0 1 1 
Value 0 1 0 0 
Weighted Sizing (.056) 0.000 0.130 0.000 0.000 
O2 Usage 1.5 cfm >> 3 cfm 3 cfm 3 cfm 
Value 1 0 0.5 0.5 
Weighted Score (.138) 0.220 0.000 0.110 0.110 





3. http://store.cyberweld.com/micowehecosy.html  
 
The DCF1 had a significantly lower score due to fogging of the chamber and the need for multiple sizes to 
support the range of patient physiology.  The FVV was at a deficite with respect to oxygen usage.  A higher fidelity 
trade study should be attempted between these two down-selected options taking into consideration the relative 
impact to cost associated with carrying multiple size masks versus the delta oxygen usage.  Finally, these options 
should be tested in a prototype chamber as the design of the gaseous portion could significant ventilation which will 
impact.  Minizing the oxygen free volume would decrease the flow rate required to maintain optimal ventilation for 
CO2 washout and defogging.   
IV. Conclusion 
A concept for a personal hyperbaric chamber was developed.  It is possible to assemble a ventilation system with 
a readily available parts that is easy to assemble, operate and provides adequate ventilation.  Work should continue 
to develop a prototype and demonstrate the treatment at Johnson Space Center.  
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Figure 7. Notional Schematic with Part Numbers.  Parts from the McMaster-Carr Equipment catalog were chosen 
to demonstrate that the system could be assembled and maintained easily. 
